Poster Abstract Session:
46. Criticare, HAIs: Pneumonia and Chlorhexidine
Thursday, October 3, 2013: 12:30 PM-2:00 PM
Room: The Moscone Center: Poster Hall C

Learning Objectives:


Target Audience: infectious diseases physicians

Tracks: Epidemiology and Infection Control, Adult ID


Healthcare-Associated Infections: Knowledge, Training, and Practice of Resident Physicians
Mohamad Fakih, MD, MPH ; Steven Minnick, MD, MBA ; Karen Huggland, MS ; Raymond Hilu, MD ; Patricia Nouhan, MD ; Elango Edhayan, MD ; Douglas Ziegler, MD ; Mark Paschall, MD ; Michael Prysak, MD ; Stuart Wertheimer, DPM ; Adonis Lorenzana, MD
  • RP survey ID week 2013.pdf (1.6 MB)

  • 210
    Development of an ICU Report Card for Infection Prevention Practice Adherence
    Marcie Richmond, MD ; Lisa Leavitt, MD ; Kate Tyner, RN ; R Jennifer Cavalieri, RN ; Trevor C Van Schooneveld, MD ; Mark E. Rupp, MD, FIDSA, FSHEA

    Infection Prevention Resources and Policies in Acute Care Hospitals: Results from a National Study
    Patricia Stone, PhD, MPH, RN, FAAN ; Monika Pogorzelska-Maziarz, PhD, MPH ; Carolyn Herzig, MS ; E. Yoko Furuya, MD, MS ; Andrew Dick, PhD ; Elaine Larson, PhD, RN, FIDSA, FSHEA

    Carbapenem Resistance Among Nosocomial Infections, a Clinico-Microbiological Profile at a Tertiary Care Center in South India
    Satyesh Chowdary Muppavarapu, Medical Student ; Danturulu Muralidhar Varma, MD ; Sudha Vidyasagar, MD ; Chiranjay Mukhopadhyay
  • Satyesh's-Report---Copy2.png (355.3 kB)

  • 213
    An Infection Prevention Education Program Targeting Resident Physicians
    Lisa Veach, MD, FACP ; Julie Gibbons, BSN, RN
  • LVEACHidweekposter.pdf (466.5 kB)

  • 214
    Evaluation of two sets of surveillance criteria for ventilator associated pneumonia in children
    Christopher Taylor, M2 ; Meera Varman, MD ; Luke Noronha, MD ; Christopher Wichman

    Implementing a VAP Bundle in Conjunction with a Compliance Audit Program Reduces VAP Rates in the NICU
    Mark Speziale, MD, PhD ; Ellen Knodel, RRT-NPS ; Nikki Tarantino, RRT

    Epidemiological and Economic Impact on the Prevention and Control of Ventilator-Associated Pneumonia in Intermediate Care Unit: A Model of Effective Analysis
    Lillyana Flores, MD ; Ricardo Valdés, MD ; Oscar Sosa, MD ; Patricia Rodríguez, MD ; Araceli Contreras ; Rafael Figueroa, MD ; Rafael Valdez, MD
  • Poster final LFR.pdf (1.0 MB)

  • 218
    Does Healthcare-Associated Pneumonia Convey a Higher Risk for Multi-Drug Resistant Organisms than Community-Acquired Pneumonia? A Propensity Score Case-Cohort Study
    Alan E. Gross, PharmD, BCPS ; Trevor C. Van Schooneveld, MD ; Mark E. Rupp, MD, FIDSA, FSHEA ; Keith M. Olsen, PharmD, FCCP, FCCM ; Thu Hong Bui ; Elsie Forsung ; Andre C. Kalil, MD, MPH

    Impact of Chlorhexidine Bathing on Central Line Associated Bloodstream Infections (CLABSI) Rates in a Tertiary-Care NICU: A Quasi-Experimental Study
    Caroline Quach, MD MSc ; Chantal Perpête, RN, LSH, LSHH ; Milagros Gonzales, MSc ; Dorothy Moore, MD, PhD ; Mario Bonenfant, RN ; Martine Chagnon, RN ; Martine Claveau, NNP ; Thérèse Perreault, MD
  • 219_IDWPOSTER.pdf (626.8 kB)

  • 220
    Impact of Daily Chlorhexidine Bath and Hand Hygiene on the Nosocomial Infection Rate in Critically Ill Patients
    Michel F Martinez-Resendez, MD ; Adrian Camacho-Ortiz Sr., MD ; Juan Rodriguez-Lopez, RN ; Alexis S Herrera-Guerra, MD ; Soraya S Mendoza-Olazaran ; Edelmiro Perez-Rodriguez, MD ; Roberto Mercado-Longoria, MD ; Elvira Garza-Gonzalez, Ph.D.

    Efficacy and Cost of Basinless Baths Compared to Chlorhexidine Bathing to Reduce Hospital Acquired Infections (HAI)
    Mary Beth Flynn Makic, RN, PhD, CNS, CCNS ; Linda Burton, RN, CIC ; Teresa Hulett, RN ; Kathleen Schomer, RN, CIC ; Michelle Barron, MD
  • IDSA poster 2013.MM.pdf (531.7 kB)

  • 222
    Impact of Chlorhexidine Bathing on Cental Line Associated Bloodstream Infections in Adult Intensive Care Units
    Atul Kothari, MD ; Jonathan Grein, MD ; Meghan Madhusudhan ; Rekha Murthy, MD

    CME Credits:

    ACPE Credits:

    ACPE Number:

    Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.